Beclomethasone dipropionate hfa
QVAR REDIHALER is a prescription inhaler containing beclomethasone dipropionate, a corticosteroid that helps reduce inflammation in the lungs. It's used to treat asthma in adults and children 4 years and older. Available in 0.04 mg and 0.08 mg per inhalation doses, manufactured by Teva Respiratory, LLC. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | QVAR REDIHALER is a prescription inhaler containing beclomethasone dipropionate, a corticosteroid that helps reduce inflammation in the lungs. It's used to treat asthma in adults and children 4 years and older. Available in 0.04 mg and 0.08 mg per inhalation doses, manufactured by Teva Respiratory, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Beclomethasone dipropionate hfa",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Beclomethasone dipropionate hfa — ANDA 207921 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207921"
}
]
|
| identifier | ANDA207921 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"fda",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Beclomethasone dipropionate hfa |
